A general practice evaluation of selexid suspension as a treatment for acute urinary tract infection.
Fifty-seven general practice patients (fifty-five females and two males) with acute uncomplicated cystitis received a 5-day course of pivmecillinam suspension at a dose of 200 mg (2 sachets) three times a day. Positive bacteriological cultures were obtained from twenty-eight patients (49%) before treatment. The bacteriological cure rate was 100%. All patients experienced some relief of symptoms and thirty-nine patients (68%) were completely symptom-free after treatment. Selexid suspension was generally well tolerated. Side-effects were reported in only four patients(6%) and no patient had to stop treatment prematurely.
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000561:Amdinocillin Pivoxil / Q000009:adverse effects / Q000627:therapeutic use*; D001437:Bacteriuria / Q000150:complications; D002986:Clinical Trials as Topic; D003556:Cystitis / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D005194:Family Practice; D005260:Female; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D010397:Penicillanic Acid / Q000627:therapeutic use*; D013535:Suspensions
D013535:Suspensions; D000561:Amdinocillin Pivoxil; D010397:Penicillanic Acid